NasdaqGS - Nasdaq Real Time Price USD

Kura Oncology, Inc. (KURA)

Compare
9.63 -0.06 (-0.62%)
At close: December 13 at 4:00:02 PM EST
9.43 -0.20 (-2.08%)
After hours: December 13 at 6:06:14 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
217,502.00
165,804.00
139,865.00
131,258.00
91,899.00
Operating Income
-217,502.00
-165,804.00
-139,865.00
-131,258.00
-91,899.00
Net Non Operating Interest Income Expense
19,950.00
13,173.00
4,025.00
792.00
2,274.00
Other Income Expense
--
--
--
--
51.00
Pretax Income
-197,552.00
-152,631.00
-135,840.00
-130,466.00
-89,625.00
Net Income Common Stockholders
-197,552.00
-152,631.00
-135,840.00
-130,466.00
-89,625.00
Diluted NI Available to Com Stockholders
-197,552.00
-152,631.00
-135,840.00
-130,466.00
-89,625.00
Basic EPS
-2.35
-2.08
-2.03
-1.97
-1.69
Diluted EPS
-2.35
-2.08
-2.03
-1.97
-1.69
Basic Average Shares
83,720.75
73,229.00
66,990.00
66,352.00
53,077.00
Diluted Average Shares
83,720.75
73,229.00
66,990.00
66,352.00
53,077.00
Total Expenses
217,502.00
165,804.00
139,865.00
131,258.00
91,899.00
Net Income from Continuing & Discontinued Operation
-197,552.00
-152,631.00
-135,840.00
-130,466.00
-89,625.00
Normalized Income
-197,552.00
-152,631.00
-135,840.00
-130,466.00
-89,625.00
Interest Income
21,560.00
14,722.00
4,254.00
1,206.00
2,852.00
Interest Expense
1,610.00
1,549.00
229.00
414.00
578.00
Net Interest Income
19,950.00
13,173.00
4,025.00
792.00
2,274.00
EBIT
-195,942.00
-151,082.00
-135,611.00
-130,052.00
-89,047.00
EBITDA
-195,084.00
-150,233.00
-134,852.00
-129,494.00
-88,853.00
Reconciled Depreciation
858.00
849.00
759.00
558.00
194.00
Net Income from Continuing Operation Net Minority Interest
-197,552.00
-152,631.00
-135,840.00
-130,466.00
-89,625.00
Normalized EBITDA
-195,084.00
-150,233.00
-134,852.00
-129,494.00
-88,853.00
12/31/2020 - 9/16/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SNDX Syndax Pharmaceuticals, Inc.
13.93
+3.41%
 
BCYC Bicycle Therapeutics plc
13.81
-31.33%
 
ACLX Arcellx, Inc.
83.80
+0.46%
 
RLAY Relay Therapeutics, Inc.
4.7100
-1.46%
 
PTGX Protagonist Therapeutics, Inc.
41.08
+1.73%
 
ANAB AnaptysBio, Inc.
15.59
+3.79%
 
OLMA Olema Pharmaceuticals, Inc.
6.75
+0.45%
 
NRIX Nurix Therapeutics, Inc.
20.27
-1.41%
 
COGT Cogent Biosciences, Inc.
8.15
-2.28%
 
MRUS Merus N.V.
42.83
+3.33%